The importance of TCF7L2

Diabetic Medicine

Volumn 24, Issue 10, 2007, Pages 1062-1066

  Weedon, M N ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Genetic association study; TCF7L2; Type 2 diabetes

Indexed keywords

METFORMIN; PLACEBO; PROTEIN DERIVATIVE; TCF7L2 PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

CLINICAL PRACTICE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; INTROSPECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOTYPE; HUMANS; LINKAGE (GENETICS); MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TCF TRANSCRIPTION FACTORS;

EID: 34548790660     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02258.x     Document Type: Review

References (35)

1. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H et al. The Wellcome Trust Case Control Consortium. Replication of genome-wide association signals in UK samples reveals risk loci for Type 2 diabetes. Science 2007 316 : 1336 1341.
2. Diabetes Genetics Initiative of Broad Institute of Harvard, MIT, Lund University and Novartis Institutes for BioMedical Research. Genome-wide association analysis identifies loci for Type 2 diabetes and triglyceride levels. Science 2007 316 : 1331 1336.
3. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL et al. A genome-wide association study of Type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007 316 : 1341 1345.
4. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007 39 : 770 775.
5. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007 445 : 881 885.
6. Grant SFA, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006 38 : 320 323.
7. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 2007 85 : 777 782.
8. Groves CJ, Zeggini E, Minton JA, Frayling TM, Weedon MN, Rayner NW et al. Association analysis of 6736 UK subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 2006 55 : 2640 2644.
9. Chandak GR, Janipalli CS, Bhaskar S, Kulkarni SR, Mohankrishna P, Hattersley AT et al. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia 2007 50 : 63 67.
10. Hayashi T, Iwamoto Y, Kaku K, Hirose H, Maeda S. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. Diabetologia 2007 50 : 980 984.
11. Horikoshi M, Hara K, Ito C, Nagai R, Froguel P, Kadowaki T. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. Diabetologia 2007 50 : 747 751.
12. Lehman DM, Hunt KJ, Leach RJ, Hamlington J, Arya R, Abboud HE et al. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with Type 2 diabetes and age of onset in Mexican Americans. Diabetes 2007 56 : 389 393.
13. Helgason A, Palsson S, Thorleifsson G, Grant SF, Emilsson V, Gunnarsdottir S et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007 39 : 218 225.
14. Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen H, Silver KD et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with Type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006 55 : 2654 2659.
15. Scott LJ, Bonnycastle LL, Willer CJ, Sprau AG, Jackson AU, Narisu N et al. Association of transcription factor 7-like 2 (TCF7L2) variants with Type 2 diabetes in a Finnish Sample. Diabetes 2006 55 : 2649 2653.
16. Smith U. TCF7L2 and type 2 diabetes - we WNT to know - commentary. Diabetologia 2007 50 : 5 7.
17. Etheridge SL, Spencer GJ, Heath DJ, Genever PG. Expression profiling and functional analysis of Wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 2004 22 : 849 860.
18. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL et al. Inhibition of adipogenesis by Wnt signaling. Science 2000 289 : 950 953.
19. Papadopoulou S, Edlund H. Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function. Diabetes 2005 54 : 2844 2851.
20. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PIW, Shuldiner AR et al., the Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006 355 : 241 250.
21. Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, Sjogren M et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with Type 2 diabetes and reduce the insulin response to glucose in non-diabetic individuals. Diabetes 2006 55 : 2890 2895.
22. Loos RJF, Franks PW, Francis RW, Barroso I, Gribble FM, Savage DB et al. TCF7L2 polymorphisms modulate proinsulin levels and β-cell function in a British Europid population. Diabetes 2007 56 : 1943 1947.
23. Munoz J, Lok KH, Gower BA, Fernandez JR, Hunter GR, Lara-Castro C et al. Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in non-diabetic women. Diabetes 2006 55 : 3630 3634.
24. Cauchi S, Meyre D, Choquet H, Dina C, Born C, Marre M et al. for the DSG. TCF7L2 variation predicts hyperglycemia incidence in a French general population: The Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Study. Diabetes 2006 55 : 3189 3192.
25. Marzi C, Huth C, Kolz M, Grallert H, Meisinger C, Wichmann HE et al. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys. Horm Metab Res 2007 39 : 46 52.
26. Freathy RM, Weedon MN, Bennett A, Hypponen E, Relton CL, Knight B et al. Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24 053 individuals. Am J Hum Genet 2007 80 : 1150 1161.
27. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003 362 : 1275 1281.
28. Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, Larkin B et al., the Neonatal Diabetes International Collaborative Group. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006 355 : 467 477.
29. Diabetes Prevention Program Research Group. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 346 : 393 403.
30. Janssens A, Gwinn M, Valdez R, Narayan KMV, Khoury MJ. Predictive genetic testing for type 2 diabetes - may raise unrealistic expectations. Br Med J 2006 333 : 509 510.
31. Weedon MN, McCarthy MI, Hitman G, Walker M, Groves CJ, Zeggini E et al. Combining information from common Type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 2006 3 : e374.
32. Janssens A, Pardo MC, Steyerberg EW, van Duijn CM. Revisiting the clinical validity of multiplex genetic testing in complex diseases. Am J Human Genet 2004 74 : 585 588.
33. Yang QH, Khoury MJ, Friedman JM, Little J, Flanders WD. How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol 2005 34 : 1129 1137.
34. Yang Q, Khoury MJ, Botto L, Friedman JM, Flanders WD. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 2003 72 : 636 649.
35. Sandhu MS, Weedon MN, Fawcett KA, Wasson J, Debenham SL, Daly A et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet 2007 8 : 951 953.